Corporate actions22 Sep 2026 · 10:48 PM IST
NATCOPHARMNatco Pharma
Gets in-principle approval for its rights issue
The approval is a step before the rights issue opens.
Price, Monday's close₹816.30▲ 0.36%
Last 5 days
What happened
- Natco Pharma received in-principle approval for its rights issue.
Read the source
This is a summary of public news about Natco Pharma, for information only. It is not a recommendation to buy, sell or hold NATCOPHARM.